Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates

Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of$ 0.84. This compares to loss of $0.78 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 88.10%. A quarter ago, it was expected that this company would post a loss of$ 0.92 per share when it actually produced a loss of $0.26, delivering a surprise of 71.74%.Over the last four quarters, the company has ...